Sort by
Items per page

Send to

Choose Destination

Search results

Items: 28


Against Strong Ethical Parity: Situated Cognition Theses and Transcranial Brain Stimulation.

Heinrichs JH.

Front Hum Neurosci. 2017 Apr 11;11:171. doi: 10.3389/fnhum.2017.00171. eCollection 2017.


Development of a Novel Vaccine Containing Binary Toxin for the Prevention of Clostridium difficile Disease with Enhanced Efficacy against NAP1 Strains.

Secore S, Wang S, Doughtry J, Xie J, Miezeiewski M, Rustandi RR, Horton M, Xoconostle R, Wang B, Lancaster C, Kristopeit A, Wang SC, Christanti S, Vitelli S, Gentile MP, Goerke A, Skinner J, Strable E, Thiriot DS, Bodmer JL, Heinrichs JH.

PLoS One. 2017 Jan 26;12(1):e0170640. doi: 10.1371/journal.pone.0170640. eCollection 2017.


Ion-Exchange Chromatography to Analyze Components of a Clostridium difficile Vaccine.

Rustandi RR, Wang F, Lancaster C, Kristopeit A, Thiriot DS, Heinrichs JH.

Methods Mol Biol. 2016;1476:269-77. doi: 10.1007/978-1-4939-6361-4_20.


MRI as a Novel In Vivo Approach for Assessing Structural Changes of Chlamydia Pathology in a Mouse Model.

Hines CD, Wang S, Meng X, Skinner JM, Heinrichs JH, Smith JG, Boddicker MA.

PLoS One. 2016 Jul 28;11(7):e0160055. doi: 10.1371/journal.pone.0160055. eCollection 2016.


Design and Purification of Subunit Vaccines for Prevention of Clostridium difficile Infection.

Karczewski J, Bodmer JL, Cook JC, Xoconostle RF, Nahas DD, Joyce JG, Heinrichs JH, Secore S.

Methods Mol Biol. 2016;1403:385-96. doi: 10.1007/978-1-4939-3387-7_20.


Quantitative In Vivo Detection of Chlamydia muridarum Associated Inflammation in a Mouse Model Using Optical Imaging.

Patel M, Lin SA, Boddicker MA, DeMaula C, Connolly B, Bednar B, Heinrichs JH, Smith JG.

Mediators Inflamm. 2015;2015:264897. doi: 10.1155/2015/264897. Epub 2015 Nov 18.


Toxicity assessment of Clostridium difficile toxins in rodent models and protection of vaccination.

Wang S, Rustandi RR, Lancaster C, Hong LG, Thiriot DS, Xie J, Secore S, Kristopeit A, Wang SC, Heinrichs JH.

Vaccine. 2016 Mar 4;34(10):1319-23. doi: 10.1016/j.vaccine.2015.11.026. Epub 2015 Nov 21.


An in vitro culture model to study the dynamics of colonic microbiota in Syrian golden hamsters and their susceptibility to infection with Clostridium difficile.

Miezeiewski M, Schnaufer T, Muravsky M, Wang S, Caro-Aguilar I, Secore S, Thiriot DS, Hsu C, Rogers I, DeSantis T, Kuczynski J, Probst AJ, Chehoud C, Steger R, Warrington J, Bodmer JL, Heinrichs JH.

ISME J. 2015 Feb;9(2):321-32. doi: 10.1038/ismej.2014.127. Epub 2014 Jul 18.


Detecting and preventing reversion to toxicity for a formaldehyde-treated C. difficile toxin B mutant.

Wang B, Wang S, Rustandi RR, Wang F, Mensch CD, Hong L, Kristopeit A, Secore S, Dornadula G, Kanavage A, Heinrichs JH, Mach H, Blue JT, Thiriot DS.

Vaccine. 2015 Jan 1;33(1):252-9. doi: 10.1016/j.vaccine.2014.06.032. Epub 2014 Jun 18.


Development of a recombinant toxin fragment vaccine for Clostridium difficile infection.

Karczewski J, Zorman J, Wang S, Miezeiewski M, Xie J, Soring K, Petrescu I, Rogers I, Thiriot DS, Cook JC, Chamberlin M, Xoconostle RF, Nahas DD, Joyce JG, Bodmer JL, Heinrichs JH, Secore S.

Vaccine. 2014 May 19;32(24):2812-8. doi: 10.1016/j.vaccine.2014.02.026. Epub 2014 Mar 21.


Development and optimization of a high-throughput assay to measure neutralizing antibodies against Clostridium difficile binary toxin.

Xie J, Horton M, Zorman J, Antonello JM, Zhang Y, Arnold BA, Secore S, Xoconostle R, Miezeiewski M, Wang S, Price CE, Thiriot D, Goerke A, Gentile MP, Skinner JM, Heinrichs JH.

Clin Vaccine Immunol. 2014 May;21(5):689-97. doi: 10.1128/CVI.00038-14. Epub 2014 Mar 12.


On the relation of psychiatric disorder and neural defect.

Heinrichs JH.

Front Psychol. 2014 Jan 29;5:40. doi: 10.3389/fpsyg.2014.00040. eCollection 2014. No abstract available.


Development and optimization of a novel assay to measure neutralizing antibodies against Clostridium difficile toxins.

Xie J, Zorman J, Indrawati L, Horton M, Soring K, Antonello JM, Zhang Y, Secore S, Miezeiewski M, Wang S, Kanavage AD, Skinner JM, Rogers I, Bodmer JL, Heinrichs JH.

Clin Vaccine Immunol. 2013 Apr;20(4):517-25. doi: 10.1128/CVI.00549-12. Epub 2013 Feb 6.


Immunogenicity in mice and non-human primates of the Group A Streptococcal J8 peptide vaccine candidate conjugated to CRM197.

Caro-Aguilar I, Ottinger E, Hepler RW, Nahas DD, Wu C, Good MF, Batzloff M, Joyce JG, Heinrichs JH, Skinner JM.

Hum Vaccin Immunother. 2013 Mar;9(3):488-96. Epub 2012 Dec 18.


The promises and perils of non-invasive brain stimulation.

Heinrichs JH.

Int J Law Psychiatry. 2012 Mar-Apr;35(2):121-9. doi: 10.1016/j.ijlp.2011.12.006. Epub 2012 Jan 17.


Pre-clinical evaluation of a 15-valent pneumococcal conjugate vaccine (PCV15-CRM197) in an infant-rhesus monkey immunogenicity model.

Skinner JM, Indrawati L, Cannon J, Blue J, Winters M, Macnair J, Pujar N, Manger W, Zhang Y, Antonello J, Shiver J, Caulfield M, Heinrichs JH.

Vaccine. 2011 Nov 8;29(48):8870-6. doi: 10.1016/j.vaccine.2011.09.078. Epub 2011 Oct 1.


Comparison of rhesus and cynomolgus macaques in a Streptococcus pyogenes infection model for vaccine evaluation.

Skinner JM, Caro-Aguilar IC, Payne AM, Indrawati L, Fontenot J, Heinrichs JH.

Microb Pathog. 2011 Jan;50(1):39-47. doi: 10.1016/j.micpath.2010.10.004. Epub 2010 Oct 28.


A real-time quantitative polymerase chain reaction assay for the detection of Chlamydia in the mouse genital tract model.

Wooters MA, Kaufhold RM, Field JA, Indrawati L, Heinrichs JH, Smith JG.

Diagn Microbiol Infect Dis. 2009 Feb;63(2):140-7. doi: 10.1016/j.diagmicrobio.2008.10.007. Epub 2008 Nov 21.


Effect of alternative aluminum adjuvants on the absorption and immunogenicity of HPV16 L1 VLPs in mice.

Caulfield MJ, Shi L, Wang S, Wang B, Tobery TW, Mach H, Ahl PL, Cannon JL, Cook JC, Heinrichs JH, Sitrin RD.

Hum Vaccin. 2007 Jul-Aug;3(4):139-45. Epub 2007 Apr 5.


A novel automated method for enumeration of Chlamydia trachomatis inclusion forming units.

Wang S, Indrawati L, Wooters M, Caro-Aguilar I, Field J, Kaufhold R, Payne A, Caulfield MJ, Smith JG, Heinrichs JH.

J Immunol Methods. 2007 Jul 31;324(1-2):84-91. Epub 2007 May 30.


Use of a whole genome approach to identify vaccine molecules affording protection against Streptococcus pneumoniae infection.

Wizemann TM, Heinrichs JH, Adamou JE, Erwin AL, Kunsch C, Choi GH, Barash SC, Rosen CA, Masure HR, Tuomanen E, Gayle A, Brewah YA, Walsh W, Barren P, Lathigra R, Hanson M, Langermann S, Johnson S, Koenig S.

Infect Immun. 2001 Mar;69(3):1593-8.


Identification and characterization of a novel family of pneumococcal proteins that are protective against sepsis.

Adamou JE, Heinrichs JH, Erwin AL, Walsh W, Gayle T, Dormitzer M, Dagan R, Brewah YA, Barren P, Lathigra R, Langermann S, Koenig S, Johnson S.

Infect Immun. 2001 Feb;69(2):949-58.


Identification and characterization of SirA, an iron-regulated protein from Staphylococcus aureus.

Heinrichs JH, Gatlin LE, Kunsch C, Choi GH, Hanson MS.

J Bacteriol. 1999 Mar;181(5):1436-43.


Regulation of protein A synthesis by the sar and agr loci of Staphylococcus aureus.

Cheung AL, Eberhardt K, Heinrichs JH.

Infect Immun. 1997 Jun;65(6):2243-9.


The molecular architecture of the sar locus in Staphylococcus aureus.

Bayer MG, Heinrichs JH, Cheung AL.

J Bacteriol. 1996 Aug;178(15):4563-70.


Characterization of the sar locus and its interaction with agr in Staphylococcus aureus.

Heinrichs JH, Bayer MG, Cheung AL.

J Bacteriol. 1996 Jan;178(2):418-23.


Molecular cloning and characterization of the hblA gene encoding the B component of hemolysin BL from Bacillus cereus.

Heinrichs JH, Beecher DJ, MacMillan JD, Zilinskas BA.

J Bacteriol. 1993 Nov;175(21):6760-6.

Supplemental Content

Loading ...
Support Center